Neurogene NGNE
NASDAQ NGNE
$26.75 +1.35 (+5.33%)
As of: Oct 21, 2026 · 2:28 PM EDT

Neurogene (NGNE) Non-Current Debt (2013)

Updated

Neurogene (NGNE) reported Non-Current Debt of -$2.6 million for FY2014, compared with $2.39 million in FY2013.

Analysis

Neurogene (NGNE) Non-Current Debt (2013) Analysis & Trends

  • According to Business Quant data, Non-Current Debt came in at $2.39 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 62.48 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 60.50 Bn
10 Neurogene 603.38 Mn -399.62 Mn - -5,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 2.04 Mn
API Access

Neurogene Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NGNE&period=max&api_key=YOUR_API_KEY